Media Preparation
M9 minimum media were prepared as follows. Na2HPO4.2H2O, KH2PO4, NaCl, NH4Cl, MgSO4, CaCl2 and glucose were obtained from Sigma-Aldrich. 13C-depleted glucose was purchased from Cambridge Isotope Laboratories and 15N-depleted (NH4)2SO4 was from Merck. Deuterium Depleted Water (DDW) containing ≤5 ppm D and 410 ppm 18O was obtained from MTC Iceberg Ltd (Moscow, Russia). M9 stock salt solutions (M9 5×SS) were prepared by dissolving 42.5 g Na2HPO4.2H2O, 15.0 g of KH2PO4 and 2.5 g of NaCl in 1000 mL of either normal milli-Q water (for Normal M9 media) or DDW (for Depleted M9 media). Both solutions were autoclaved before proceeding to M9 media preparation. M9 media were prepared by mixing 800 mL of either normal milli-Q water (for Normal M9 media) or DDW (for Depleted M9 media), 200 mL of the corresponding M9 5xSS, 2.0 mL of 1M MgSO4, 0.1 mL of 1M CaCl2, 5 g of glucose and 1 g of (NH4)2SO4 (isotopically normal for Normal M9 media and 13C-depleted glucose and 15N-depleted (NH4)2SO4 for Depleted M9 media). These media were filtered using 0.2 µm polyether sulfone (PES) filters (VWR) before use.
E. coli growth
For each set of experiments, E. coli BL 21 strain was grown on plates containing LB agar (Sigma). A single colony was transferred to a tube containing 6 mL of Normal M9 media and grown for 36 h. These bacteria were further diluted (1:500) into tubes containing either Normal or Depleted M9 media and put into honeycomb well plates (BioScreen, Finland) in 21 replicates. Bacterial growth was monitored by measuring light diffraction on a BioScreen C instrument (BioScreen, Finland) at 37°C.
TPP sample preparation
E. coli BL21 grown in Normal and Depleted M9 media were diluted (1:500) into tubes containing either Normal or Depleted M9 media in flasks. After 36 h of growth, the bacteria in each flask were collected, washed, resuspended in PBS with protease inhibitor (5892791001, Sigma) and lysed by probe sonication. The protein solution was collected after centrifuge and divided into 8 aliquots. These aliquots were incubated for 3 min at either 37, 43, 49, 55, 61, 67, 73 or 79°C. After that the samples were kept at RT for 5 min to cool down and ultra-centrifuged at 35,000 rpm/min at 4°C for 30 min. Afterwards, the supernatant was collected, reduced with 10 mM DTT (10708984001, Sigma) and alkylated with 25 mM IAA (I1149, Sigma). The samples were precipitated using cold acetone at -20°C overnight, digested by Lys C (125–05061, Wako Chemicals GmbH) at a 1:75 enzyme to protein ratio for 6 h at 30°C and then by trypsin (V5111, Promega) (1:50 enzyme to protein ratio) overnight. After labeling using 16 TMTpro reagents (A44520, Thermo Fisher Scientific) according to manufacturer’s instructions, multiplexing and desalting with C18 Sep-pak columns (WAT054960, Waters), the peptides samples were fractionated using a Dionex Ultimate 3000 UPLC system (Thermo Fisher Scientific) as described before 20. Every 8 fractions were combined to a single pool and 12 such pools for each TMT-multiplexed sample set were analyzed by nanoLC-MS/MS as customary in shotgun proteomics.
NanoLC-MS/MS analysis
NanoLC-MS/MS analyses were performed on an Orbitrap Fusion Lumos mass spectrometer (Thermo Fisher Scientific). The instrument was equipped with an EASY ElectroSpray source and connected online to an Ultimate 3000 nanoflow UPLC system. The samples were pre-concentrated and desalted online using a PepMap C18 nano-trap column (length - 2 cm; inner diameter - 75 µm; particle size - 3 µm; pore size - 100 Å; Thermo Fisher Scientific) with a flow rate of 3 µL/min for 5 min. Peptide separation was performed on an EASY-Spray C18 reversed-phase nano-LC column (Acclaim PepMap RSLC; length - 50 cm; inner diameter - 2 µm; particle size - 2 µm; pore size – 100 Å; Thermo Scientific) at 55 °C and a flow rate of 300 nL/min. Peptides were separated using a binary solvent system consisting of 0.1% (v/v) FA, 2% (v/v) ACN (solvent A) and 98% ACN (v/v), 0.1% (v/v) FA (solvent B). They were eluted with a gradient of 3–26% B in 97 min, and 26–95% B in 9 min. Subsequently, the analytical column was washed with 95% B for 5 min before re-equilibration with 3% B. The mass spectrometer was operated in a data-dependent acquisition mode. A survey mass spectrum (from m/z 375 to 1500) was acquired in the Orbitrap analyzer at a nominal resolution of 120,000. The automatic gain control (AGC) target for was set as 100% standard, with the maximum injection time of 50 ms. The most abundant ions in charge states 2+ to 7+ were isolated in a 3 s cycle, fragmented using HCD MS/MS with 33% normalized collision energy, and detected in the Orbitrap analyzer at a nominal mass resolution of 50,000. The AGC target for MS/MS was set as 250% standard with a maximum injection time of 100 ms, whereas dynamic exclusion was set to 45 s with a 10-ppm mass window.
Expression and purification of luciferase YY5
Part of this work was performed by the Protein Science Facility at Karolinska Institutet, Stockholm. The construct psfLucYY5 was transformed into E. coli BL21 (DE3) T1R pRARE2 cells in Normal and Depleted M9 media containing 50 µg/mL ampicillin and 34 µg/mL chloramphenicol at 37°C. The bacterial growth was monitored by regular OD measurements. Protein expression of the fusion proteins was induced by the addition of 0.5 mM isopropyl-1-thio-β-D-galactopyranoside (IPTG, Merck). The cells were harvested after 16 h by centrifugation, and the pellet was resuspended in lysis buffer including 100 mM HEPES, 500 mM NaCl, 10% glycerol, 10 mM imidazole, 0.5 mM TCEP, pH 8.0, 1 mg/mL lysozyme, 0.1% DDM, 1 mM MgSO4, protease inhibitors (complete EDTA-free 0.5 tab/mL), and benzonase (0.125 U/mL). After centrifugation, the samples were loaded onto a resin column (GE Healthcare) equilibrated with binding buffer (20 mM HEPES, 500 mM NaCl, 10% glycerol, 10 mM imidazole and 0.5 mM TCEP, at pH 7.5). The column was washed with binding buffer followed by washing buffer (same as binding buffer but with 30 mM imidazole), and then recombinant luciferase YY5 was eluted with a similar buffer containing 500 mM imidazole. Fractions containing luciferase YY5 were combined and applied to a PD 10 column (GE Healthcare) equilibrated with 50 mM Tris-HCl at pH 7.8. The size and purity of recombinant luciferase YY5 was confirmed by SDS-PAGE.
Expression and purification of human Trx
The Trx expression plasmid (Supplementary Fig. 3a-c) was transformed into E. coli BL21 (DE) in Normal and Depleted M9 media containing 50 µg/mL kanamycin (Merck, K1377) and the expression and purification of Trx was performed as described above. Fractions containing Trx according to SDS-PAGE analysis were pooled together and TEV protease (Sigma) was added to the protein sample at a 1:30 molar ratio. The mixture was incubated at 4°C overnight. The His-tag was removed by loading the protein sample onto a 1 mL HisTrap column (GE Healthcare) pre-equilibrated with TEV cleavage reaction buffer supplemented with 20 mM imidazole. The flow-through containing cleaved Trx protein was collected and the purification fractions were analyzed by SDS-PAGE.
Expression and purification of BsDHFR
The BsDHFR expression plasmid (Supplementary Fig. 4a and 4b) was transformed into E. coli BL21 (DE) in Normal and Depleted M9 media containing 50 µg/mL kanamycin and the expression and purification of BsDHFR was performed as above.
Expression and purification of Pfu
The construct Pfu DNA polymerase with Sso7d processivity-enhancing domain was transformed into E. coli BL21 (DE3) T1R cells in Normal and Depleted M9 media containing 50 µg/mL ampicillin and 34 µg/mL chloramphenicol. The expression and purification of BsDHFR was performed as above.
Size exclusion chromatography (SEC)
SEC purification of the recombinant proteins was performed on a Dionex Ultimate 3000 UPLC system (Thermo Fisher Scientific) with a 25 cm Waters column (2.1 mm ID; particle size 3.5 µm; pore size 300 Å) at a flow rate of 300 µL/min. Fractionation of luciferase YY5, BsDHFR and Pfu were performed using 2× phosphate-buffered saline diluted from 10× PBS (Lonza, 17517Q). Trx was purified using 50mM Tris-HCl at pH 7.5 containing 2 mM EDTA. The elution was monitored by UV absorbance at 280 and 214 nm.
Strong cation exchange (SCX) chromatography
Luciferase YY5 isolated with SEC was additionally purified by SCX using a Dionex Ultimate 3000 UPLC system (Thermo Fisher Scientific) with ProPac Strong Cation-Exchange Column (4×250mm, Thermo Fisher Scientific) at a flow rate of 500 µL/min. Fractionation was performed using a binary solvent system consisting of 12.5 mM sodium phosphate, pH 6.0 (solvent A) and 12.5 mM sodium phosphate, 1 M NaCl, pH 6.0 (solvent B). Elution was done with a 30 min gradient from 1–58% B monitored by UV absorbance at 280 nm. Two fractions showing luciferase activity were collected and used for further analysis.
Measurements of luciferase YY5 activity
Buffered co-factor solution (8 mL) was prepared containing 1 mM DTT, 0.2 mg/mL BSA, 5 mM of MgCl2, 4 mM DTT, 100 µM D-luciferin and 100 mM Tris-HCl at pH 7.8. 50 µL of each SCX fraction was mixed with 50 µL buffered co-factor solution in a 96-well microplate well and the luminescence was measured using the Tecan Infinite M2000 PRO microplate reader. The luminescence of each fraction was normalized by the total 280 nm UV absorbance of the SCX fraction.
Thermal stability assay of luciferase YY5
The protein concentration of Normal and Ultralight SEC-SCX purified luciferase YY5 was determined by microBCA and 50 µL of 0.2 µg/mL enzyme was heated at 50°C for 5-120 min. After cooling to RT, the enzyme solution was mixed with 50 µL of the reaction buffer containing 1 mM DTT, 0.2 mg/mL BSA, 5 mM of MgSO4, 4 mM DTT, 100 µM D-luciferin and 100 mM Tris−HCl at pH 7.8. The luciferase activity was measured at 25°C using the Tecan Infinite M2000 PRO microplate reader.
Measurement of Trx activity
The assay was performed at RT using 50 mM Tris-HCl containing 2 mM EDTA at pH 7.5 and 200 µM NADPH (Roche, 10107824001). A 60 µL aliquot of each Trx SEC fraction was mixed in a 96-well microplate well with 30 µL buffered enzyme solution containing 15 nM thioredoxin reductase and 10 µL of insulin (Sigma, I0516) at a concentration ranging from 0 to 160 µM (the latter corresponds to 1 mg/mL). NADPH consumption was measured immediately every minute by the decrease of absorbance at 340 nm during the initial linear phase of reaction in the Tecan Infinite M2000 PRO microplate reader. The magnitude of the absorbance decrease at 340 nm of each fraction was normalized by the total UV absorbance at 280 nm of the Trx SEC fraction.
Measurement of BsDHFR activity
The assay was performed at RT using 50 mM Tris-HCl at pH 7.5. A 60 µL aliquot of each BsDHFR SEC fraction was mixed in a 96-well microplate well with 30 µL buffered enzyme solution containing 200 µM dihydrofolic acid (Merck, D7006). NADPH consumption was measured immediately by the decrease of absorbance at 340 after a concentration ranging from 0 to 100 µM NADPH was added.
PCR and RT-PCR catalyzed by recombinant Pfu
RNA was extracted from 107 A549 cells and purified using a PureLink RNA Mini Kit (Thermo Fisher Scientific, 12183018A). A cDNA library was prepared using the High-Capacity cDNA Reverse Transcription Kit with RNase Inhibitor (Thermo Fisher Scientific, 4374966) according to manufacturer’s instructions. RT-PCR and PCR were performed with 0-2 µg cDNA in 20 mM Tris-HCl containing 50 mM KCl, 10 mM (NH4)SO4, 2 mM Triton X-100 and 0.1 mg/mL BSA (PCR buffer) at pH 8.8 with 0.2 mM dNTP (Thermo Fisher Scientific, N8080261), and 1 X SYBR green I (Thermo Fisher Scientific, 10710004). Human gene GAPDH (10 µM, 131 bp) was used in the assay and the sequences of the primers were: 5' to 3' GTCTCCTCTGACTTCAACAGCG (Forward) and 5' to 3' ACCACCCTGTTGCTGTAGCCAA (Reversed) (Thermo Fisher Scientific). Normal or Ultralight Pfu purified by SEC was diluted with PCR buffer to 30 ng/mL and 1 mL was added to each 20 µL reaction volume. The PCR program on SimpliAmp Thermal Cycler (Thermo Fisher Scientific) was 98°C for 2 min → 98°C for 10 s → 56°C for 30 s → 72°C for 30 s for 34 cycles and keep the reaction at 72°C for 5 min. RT-PCR was performed on Applied Biosystems Fast 7500 (Thermo Fisher Scientific) using the same program as PCR.
The gel for agarose gel electrophoresis was prepared by suspending 1 Advance Agarose Tablet (Genetics, AG11) in 50 mL TBE buffer (89 mM Tris-borate and 2 mM EDTA, pH 8.3). each PCR final solution was mixed with 2 µL FastDigest Green Buffer (Thermo Fisher Scientific, B72) and 15 µL mixture was loaded in the gel. Then the gel was run at 80-150 V until the dye line reached ca. 75-80% of the gel length. Afterwards, the DNA fragment was visualized under UV light at 280 nm.
Bottom-up proteomics data analysis
The LC-MS/MS raw files were processed by an in-house modified version of MaxQuant software (version 1.6.2.3) recognizing TMTpro as an isobaric mass tag using the “Specific Trypsin/P, Lyc/P” digestion mode with maximum two missed cleavages as described before 20. The MS/MS spectra were searched against the Uniprot Escherichia coli BL21 database (UP000290528, containing 4,339 entries, last modified on January 6, 2020).
Top-down mass spectrometry analysis analysis
The SEC or SCX fractions were concentrated using a 3 kDa centrifugal filter (Merck, UFC500324). The proteins were desalted using ZipTip with 0.6 µL C4 resin (Merck, ZTC04S096). On-line LC-MS/MS analysis was performed using a Dionex Ultimate NCS-3500RS Nano System coupled to an Orbitrap Fusion Lumos mass spectrometer equipped with a HESI Ion Source (all – Thermo Fisher Scientific).
Protein separation online with MS was performed using a C4 reversed-phase PepMap™ 300 micro-flow HPLC column (particle size 5 µm, 1 mm ID × 15 cm, Thermo Fisher Scientific) enclosed in a column oven compartment maintained at 45°C, at a flow rate of 30 µL/min. 1 µg of protein sample was loaded and separated using a binary solvent system consisting of Solvent A (2% acetonitrile, 98% water and 0.1% formic acid) and Solvent B (2% water, 98% acetonitrile and 0.1% formic acid). The mobile phase composition was 5% B from 0 to 2 min, followed by a 5-30% B gradient from 2 to 5 min, 30-95% B from 5 to 25 min, 95-5% B from 34 to 35 min and 5% B from 35 to 40 min. The electrospray voltage was 3.7 kV with sheath gas at 15 units, auxiliary gas at 5 units and the vaporizer temperature at 75°C. The capillary temperature was set at 300°C. The RF lens amplitude was set at 30% and an additional 15 V voltage difference was applied within the source region to facilitate ion desolvation. All mass spectra were acquired in the positive ion mode with the profile data type. Application mode was set at “intact protein” with the collision gas pressure 1 mTorr. The nominal mass resolution at m/z 200 for luciferase and Pfu was 15,000, for Trx and BsDHFR - 120,000, with 200% Normalized AGC and 10 microscans over a mass range of m/z 500-1500. For tandem mass spectrometry, the most abundant charge states of the protein ions were selected in a quadrupole mass filter with isolation window of 3.0 m/z units for higher-energy collision dissociation (HCD) with normalized collision energy set at 20%. The range of charge states was 10-100 with the underdetermined charge states included. The MS/MS spectra were acquired with 3 dependent MS/MS events with a nominal mass resolving power of 120,000 with 5 microscans, over a mass range of m/z 400-2000, with 500% Normalized AGC Target and Auto Maximum Injection Time. The Dynamic exclusion was operated with exclusion duration of 30 s, mass width (High/Low) of 1.5 m/z units and the repeat count set at 1. All mass spectra were analyzed, including isotope and charge deconvolution, using Xcalibur 4.3 (Thermo Fisher Scientific) and the Average Over Selected Retention Time and ReSpect™ (Isotopically Unresolved for luciferase YY5 and Pfu, Isotopically Resolved for Trx and BsDHFR) algorithms in Thermo Scientific™ BioPharma Finder™ 2.0 software. Protein mass tolerance was set to 20 ppm, and data were searched against the known protein amino acid sequence, allowing for amidation (DE, C-term), acetylation (N-term), biotinylation (K), methylation (KR), oxidation (MW) and deamidation (NQ) as variable modifications.
FT IsoR MS analysis
Bacterial lysate was digested as above, and after desalting the peptides were analyzed by nanoLC-MS/MS. Mass spectra were acquired on an Orbitrap Fusion Lumos Mass in the data-independent mode with z≥2 peptides selected for MS/MS in an isolation window 1000 m/z units wide centered at m/z 800. MS/MS was performed with HCD energy set at 50 NCE. The detection range was from m/z 50 to 200, with the nominal mass resolving power of 60,000. Data processing was done using a home-written R script analyzing the fine isotopic structure of the immonium ions of amino acids Pro, Val and Leu/Ile.